TRX2 (trichos=hair in ancient greek; 2=second generation) is one of the world’s leading research projects exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia (AGA). The project has been made possible through Oxford BioLabs Ltd. and former scientists from the University of Oxford, UK. TRX2 follows several independent research paths including:<br /><br />1) Hair growth<br /><br />2) The prevention of hair loss<br /><br />3) A cure against Androgentic Alopecia and other hair growth disorders
